Skip to main content

Publisher: Elsevier

Volume 7, Number 4, 15 February 2002

VEGF therapy in heart disease: for better or for worse?
pp. 209-211(3)
Author: Springer, M.L.

Favourites:
ADD

New vaccines: damming for multi-strain organisms?
pp. 212-213(2)
Author: Fricker, J.

Favourites:
ADD

Electronic DPI for insulin
pp. 213-214(2)
Author: Whelan, J.

Favourites:
ADD

New promises for schizophrenia therapy
pp. 215-216(2)
Author: Sridhar, N.

Favourites:
ADD

News in brief
pp. 217-221(5)
Authors: Clough, J.; Milburn, J.; Ramster, B.

Favourites:
ADD

People
pp. 221-222(2)
Author: Lawrence, R.N.

Favourites:
ADD

William Pardridge discusses the lack of BBB research
pp. 223-226(4)
Author: Lawrence, R.N.

Favourites:
ADD
Favourites:
ADD

The utility of predictivity in drug discovery and use
pp. 228-229(2)
Author: Peet, N.P.

Favourites:
ADD

Evaluating R&D projects and portfolios
pp. 230-231(2)
Author: Porkolab, L.

Favourites:
ADD
Favourites:
ADD

Target validation of G-protein coupled receptors
pp. 235-246(12)
Authors: Wise, A.; Gearing, K.; Rees, S.

Favourites:
ADD

Bacterial toxins as tools for mucosal vaccination
pp. 247-258(12)
Authors: Mrsny, R.J.; Daugherty, A.L.; McKee, M.L.; FitzGerald, D.J.

Favourites:
ADD
Favourites:
ADD

Monitor: molecules and profiles
pp. 268-269(2)
Author: Langston, S.

Favourites:
ADD

Novel antitumour molecules
pp. 269-272(4)
Author: Westwell, A.D.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more